SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus

Journal of Clinical Investigation

Volumn 108, Issue 6, 2001, Pages 861-869

  Billaut Mulot, O ^a   Cocude, C ^a   Kolesnitchenko, V ^a   Truong, M J ^a   Chan, E K L ^a   Hachula, E ^a   De la Tribonniere X ^a   Capron, A ^a   Bahr, G M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CELL ANTIGEN; GENE PRODUCT; PROTEIN SS 56; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE STRUCTURE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOANTIGENS; BASE SEQUENCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA, COMPLEMENTARY; FEMALE; HELA CELLS; HIV INFECTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SEQUENCE HOMOLOGY, AMINO ACID; SJOGREN'S SYNDROME; UBIQUITIN-PROTEIN LIGASES;

EID: 0034829948     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113469     Document Type: Article

References (51)

1. Ro(SS-A) and anti-Ro(SS-A): An update
2. Anti-Ro (SSA) antibodies: Clinical significance and biological relevance
3. Sjogren syndrome: Autoantibodies to cellular antigens. Clinical and molecular aspects
4. Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5- HT(4) receptor
5. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model
6. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice
7. Autoantibodies typical of non-organ-specific autoimraune diseases in HIV-seropositive patients
8. Molecular definition and sequence motifs of the 52-kD component of human SSA/Ro autoantigen
9. Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen
10. Isolation and analysis of cDNA clones expressing human lupus La antigen
11. Cytoplasmic accumulation of the 52 kDa Ro/SS-A nuclear autoantigen in transfected cell lines
12. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective SS rRNA precursors
13. Involvement of the Xenopus laevis Ro60 autoantigen in the alternative interaction of La and CNBP proteins with the 5′UTR of L4 ribosomal protein mRNA
14. Expression and DNA binding of the human 52 kDa Ro/SSA autoantigen
15. Characterization of DNA binding properties and sequence specificity of the human 52 kDa Ro/SS-A (Ro52) zinc finger protein
16. Transcription termination facror La is also an initiation factor for RNA polymerase III
17. The human autoantigen La/SS-B accelerates herpes simplex virus type 1 replicarion in transfected mouse 3T3 cells
18. Pyrimidine tract binding protein and La autoantigen interact differently with the 5′ untranslated regions of lentiviruses and oncoretrovirus mRNAs
19. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate
20. Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins
21. The Ro small cytoplasmic ribonucleoproteins: Identificarion of the antigenic protein and irs binding site on the Ro RNAs
22. Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies
23. Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins
24. The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells
25. Selective regulation of human immunodeficiency virus (HIV)-infected CD4+ lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice
26. Macrophage stimulation with Mutabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPβ and STAT1: Role of CD14 and Toll-like receptors 2 and 4
27. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
28. Assessment of the European classification criteria for Sjogren syndrome in a series of clinically defined cases: Results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren syndrome
29. Interleukin-18 modulates immune responses induced by HIV-I Nef DNA prime/protein boost vaccine
30. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
31. Isolation of a cDNA for a novel human RING finger protein gene RNF18, by the virtual transcribed sequence (VTS) approach(I)
32. Autoantibody responses to the "native" 52 kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren syndrome
33. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions
34. Developmentally regulated expression of a human "finger"-containing gene encoded by the 5′ half of the rettransforming gene
35. Molecular cloning of a new interferoninduced factor that represses human imnmnodeficiency virus type I long terminal repeat expression
36. Zinc fingers: A novel protein fold for nucleic acid recognition
37. Characterization of murine monoclonal antibodies against the Ro52 autoantigen
38. Ro 52kD autoantibodies are detected in a subset of ANA-negative sera
39. Recombinant 52kDa Ro(SSA) ELISA detects autoantibodies in Sjogren syndrome sera that go undetected by conventional serologic assays
40. Anti-SSA/Ro antibody determination by enzyme-linked inmmunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening
41. Autoantibodies in male homosexuals and HIV infection
42. Extrahepatic manifestations of chronic hepatis C infection and the interrelationship between primary Sjogren syndrome and hepatitis C in Swedish patients
43. Reactivity of sera from systemic lupus erythematosus and Sjogren syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen
44. La autoantigen alleviates translational repression by the S′ leader sequence of the human immunodeficiency virus type 1 mRNA
45. Direct interactions between auroantigen La and human immunodeficiency virus leader RNA
46. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells
47. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes
48. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages
49. La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis
50. Stressinduced cell surface expression and antigenic alteration of the Ro/SSA autoantigen
51. Enhanced membrane expression of the 52 kDa RO(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alpha